

(Sharecast News) - Oxford BioDynamics, a precision clinical diagnostics company leveraging its 'EpiSwitch 3D' genomics platform, announced the success...


Oxford BioDynamics PLC - Oxford, England-based biotechnology company has two blood testing products on market, the PSE prostate cancer screening test ...


(Sharecast News) - Clinical diagnostics specialist Oxford BioDynamics announced on Monday that Dr Jon Burrows had resigned from his positions as chief...


(Alliance News) - London's FTSE 100 closed higher on Monday, although bookmakers suffered, as the UK prime minister played down rumours of a capital g...


(Alliance News) - Oxford BioDynamics PLC on Monday launched a strategic review after warning it would need additional cash resources by early 2025.


(Alliance News) - Oxford BioDynamics PLC on Tuesday reported strong revenue growth on the back of the increased commercialisation of its EpiSwitch gen...


(Alliance News) - Oxford BioDynamics PLC on Tuesday announced the development of a canine cancer diagnostic test based on its EpiSwitch non-invasive p...